HI
FOLD

Harbour Investments’s Amicus Therapeutics FOLD Stock Holding History

Harbour Investments’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318 Buy
+22
New +$315 ﹤0.01% 4350
2025
Q4 		– Sell
-180
Closed -$1.42K – 3919
2025
Q3 		$1.42K Buy
+180
New +$1.28K ﹤0.01% 3352

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Harbour Investments's FOLD Position: Q1 2026 in Review

Harbour Investments opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 22 shares worth $318. The stake represents ﹤0.01% of the portfolio and ranks #4350 among its holdings. This is a return to the name: Harbour Investments previously reported a position in FOLD as recently as Q3 2025.

Harbour Investments first reported a position in FOLD in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.42K in Q3 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Harbour Investments held 22 shares of Amicus Therapeutics worth $318 as of Q1 2026.
  • Amicus Therapeutics was a new Harbour Investments position in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4350 holding.
  • Harbour Investments first reported a position in Amicus Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Harbour Investments's Amicus Therapeutics position peaked at $1.42K in Q3 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.